Plus therapeutics completes enrollment of the original three patients required for cohort 8 of respect-gbm phase 1/2a trial

Presentation of data from respect-gbm phase 1/2a and phase 2b trials expected second half of 2023 presentation of data from respect-gbm phase 1/2a and phase 2b trials expected second half of 2023
PSTV Ratings Summary
PSTV Quant Ranking